Home | The European House - Ambrosetti

COVID-19 Weekly Focus

A special edition of the international publication “The Magazine”, published every Friday until the end of the pandemic emergency. The number of weekly cases has increased in the world compared to last week (+20%). As a countermeasure, the European Medicines Agency (EMA) approved Valneva (a new French vaccine), that thus becomes the sixth vaccine authorized to counter the spread of the virus. Valneva is supposed to target individuals aged between 18 and 50 years old. 

Read the Focus